Results 131 to 140 of about 31,891 (279)

Characteristic of Endometrial stromal sarcoma by algorithm of potential biomarkers for uterine mesenchymal tumor [PDF]

, 2023
Takuma Hayashi, Kaoru Abiko, Nobuo Yaegashi, Shoko Nishikawa, Ikuo Konishi   +4 more
openalex   +1 more source

Clinical significance and immune microenvironment association of cuproptosis‐related genes in pan‐cancer

Experimental Physiology, EarlyView.
Abstract Recent studies highlight the important roles of cuproptosis in cancer cells. However, the roles of the cuproptosis‐related genes (CRGs) in different cancers are still not fully understood. Comprehensive analysis was performed using open‐source bioinformatic platforms to disclose the expression profiles, prognostic significance, genomic and ...
Xinyu Ge, Kaijing Wang, Tian Zhao, Jinyi Wang, Jie Liu, Zhengliang Sun, Zhengjun Chai, Wen Zhang, Chengbao Li, Yan Xu, Guohan Chen   +10 more
wiley   +1 more source

Endometrial stromal sarcoma: A review of the literature

Indian Journal of Medical and Paediatric Oncology, 2012
Endometrial stromal sarcomas are rare malignant tumors of the uterus, and most of the information available in literature is based on small series or case reports.
Geetha Puliyath, M Krishnan Nair
doaj   +1 more source

Interleukin-13 and tumor necrosis factor-β differentially regulate the production of cytokines by cultured human endometrial stromal cells [PDF]

, 2003
Kaei Nasu, Junichiro Fukuda, Bing Sun, Masakazu Nishida, Isao Miyakawa   +4 more
openalex   +1 more source

Co-Occurrence of Adrenocortical Carcinoma and Gastrointestinal Stromal Tumor in a Patient with Neurofibromatosis Type 1 and a History of Endometrial Cancer [PDF]

, 2020
Ilona Minkiewicz
openalex   +1 more source

Targeting Immune Checkpoints: Basic Signaling Pathways and Clinical Translation in Cancer Therapeutics

MedComm – Oncology, Volume 4, Issue 3, September 2025.
Immune checkpoints in tumor immunotherapy. Ligand binding to the receptor inhibits immune cell function, promotes tumor cell immune escape, and suppresses the immune response. The pathways of action are VISTA‐IGSF11, TIM‐3‐Ceacam1, CD47‐SIRPα, CTLA‐4‐CD80/CD86, PD‐L1‐PD‐1, MHC‐1‐LILRB, and CD24 ‐ Siglec ‐10. There are also other immune checkpoints such
Han Sun, Dan Huang, Huiling Zhang, Mingyuan Dong, Simiao Wang, Man Sun, Jiayi Liu, Yiqi Wang, Xiaojie Qu, Xuefeng Li, Zhaogang Yang   +10 more
wiley   +1 more source

Vaginal Cellular Angiofibroma: Report of a Rare Case with Literature Review

Journal of Mid-Life Health
Cellular angiofibroma (CA) is a relatively recently described, rare, benign soft tissue tumor that predominantly occurs in the vulvoperineal region. It was first described in 1997 as a mesenchymal-origin tumor composed of connective (fibrous) tissue and ...
G. Anju, Meenakshi Rao, Garima Yadav, Pratibha Singh   +3 more
doaj   +1 more source

Single-Stage Resection of a Mixed Endometrial Stromal Sarcoma and Smooth Muscle Tumor With Intracardiac and Pulmonary Extension [PDF]

, 2006
Maria Coganow, Biplab Das, Ellen Chen, Juan A. Crestanello   +3 more
openalex   +1 more source

A Role for Malignant Brain Tumor Domain-Containing Protein 1 in Human Endometrial Stromal Cell Decidualization [PDF]

, 2020
Sangappa B. Chadchan, Vineet K. Maurya, Gwendalyn L. Krekeler, Emily S. Jungheim, Ramakrishna Kommagani   +4 more
openalex   +1 more source

Multifactorial construction of low‐grade and high‐grade endometrial cancer recurrence prediction models

International Journal of Gynecology &Obstetrics, Volume 170, Issue 2, Page 816-826, August 2025.
Abstract Objective To analyze independent risk factors for endometrial cancer (EC), a common female cancer globally, and construct individualized prediction models for EC recurrence. Methods The EC patients from the medical record system were divided into low‐grade (n = 392) and high‐grade (n = 183) groups.
Yachai Li, Jia Yan, Yuanmei Deng, Peixuan Wang, Xue Bai, Wei Qin   +5 more
wiley   +1 more source